Page last updated: 2024-08-21

thiazoles and Medulloblastoma

thiazoles has been researched along with Medulloblastoma in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beauchamp, EM; Bell, JB; Blyth, GT; Clymer, J; Eckerdt, F; Goldman, S; Platanias, LC1
Cho, YJ; Liu, J; MacDonald, TJ; Petersen, W; Schneiderjan, M; Yuan, L; Zhang, H1
Chen, SM; Hsieh, LL; Huang, SF; Li, YY; Lui, TN; Salazar, N; Tseng, YY; Tu, CH1
Chen, XY; Fan, SH; Kong, QY; Li, H; Liu, J; Shu, XH; Wang, Q; Wen, S; Wu, ML1
Cho, BK; Cho, SH; Choi, SA; Kim, CY; Kim, SK; Kim, YH; Lee, SJ; Phi, JH; Wang, KC1
Ghassemifar, S; Mendrysa, SM1

Other Studies

6 other study(ies) available for thiazoles and Medulloblastoma

ArticleYear
Pharmacological mTOR targeting enhances the antineoplastic effects of selective PI3Kα inhibition in medulloblastoma.
    Scientific reports, 2019, 09-06, Volume: 9, Issue:1

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Nucleus; Class I Phosphatidylinositol 3-Kinases; Female; Humans; Imidazoles; Medulloblastoma; Mice, Nude; Protein Kinase Inhibitors; Sarcoma, Ewing; Signal Transduction; Thiazoles; TOR Serine-Threonine Kinases; Triazines; Xenograft Model Antitumor Assays; Zinc Finger Protein GLI1

2019
Dasatinib suppression of medulloblastoma survival and migration is markedly enhanced by combining treatment with the aurora kinase inhibitor AT9283.
    Cancer letters, 2014, Nov-01, Volume: 354, Issue:1

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aurora Kinase A; Autophagy; Benzimidazoles; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dasatinib; Enzyme Inhibitors; G2 Phase; Humans; Medulloblastoma; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Tumor Suppressor Protein p53; Urea

2014
Blockade of Inhibitors of Apoptosis Proteins in Combination with Conventional Chemotherapy Leads to Synergistic Antitumor Activity in Medulloblastoma and Cancer Stem-Like Cells.
    PloS one, 2016, Volume: 11, Issue:8

    Topics: Antineoplastic Agents; Apoptosis; Autophagy; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Survival; Cerebellar Neoplasms; Cisplatin; Drug Synergism; Drug Therapy, Combination; Humans; Medulloblastoma; Neoplastic Stem Cells; Oligopeptides; Thiazoles; Vincristine

2016
Inhibition of NF-κB signaling commits resveratrol-treated medulloblastoma cells to apoptosis without neuronal differentiation.
    Journal of neuro-oncology, 2011, Volume: 104, Issue:1

    Topics: Anticarcinogenic Agents; Apoptosis; Cell Line, Tumor; Cerebellum; Flow Cytometry; Humans; Lipopolysaccharides; Medulloblastoma; Neurons; NF-kappa B; Proline; Protein Array Analysis; Resveratrol; Signal Transduction; STAT3 Transcription Factor; Stilbenes; Tetrazolium Salts; Thiazoles; Thiocarbamates; Time Factors

2011
Growth-inhibitory effect of neurotrophin-3-secreting adipose tissue-derived mesenchymal stem cells on the D283-MED human medulloblastoma cell line.
    Journal of neuro-oncology, 2012, Volume: 106, Issue:1

    Topics: Adipose Tissue; Autophagy; beta-Galactosidase; Blotting, Western; Brain Neoplasms; Cell Differentiation; Cell Movement; Cell Separation; Coculture Techniques; Coloring Agents; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Humans; In Situ Nick-End Labeling; Medulloblastoma; Mesenchymal Stem Cells; Neurotrophin 3; Plasmids; Real-Time Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles

2012
MDM2 antagonism by nutlin-3 induces death in human medulloblastoma cells.
    Neuroscience letters, 2012, Mar-28, Volume: 513, Issue:1

    Topics: Antibiotics, Antineoplastic; Apoptosis; Blotting, Western; Brain Neoplasms; Cell Cycle; Cell Death; Cell Line, Tumor; Coloring Agents; Doxorubicin; Humans; Imidazoles; Medulloblastoma; Piperazines; Proto-Oncogene Proteins c-mdm2; Tetrazolium Salts; Thiazoles; Tumor Suppressor Protein p53

2012